Stada seeks €1.5bn of debt to finish LBO

Private equity firms Bain Capital and Cinven are financing their purchase of a further 28.3% stake in Stada Arzneimittel, the German pharmaceutical group, in the euro leveraged finance markets this week, and are having to contend with investors who are in a risk-averse mood.

  • By Victor Jimenez
  • 27 Nov 2018
A year after Bain and Cinven bought a controlling stake in Stada, the fourth largest European pharmaceuticals group, they are taking their stake up to 93.6% after a public delisting tender offer. Stada will be delisted, with the remaining shares held by some retail and institutional investors without ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Deutsche Bank 3,728.01 21 7.14%
2 Credit Agricole CIB 3,101.01 16 5.94%
3 Goldman Sachs 3,092.70 16 5.92%
4 BNP Paribas 2,926.68 24 5.61%
5 Citi 2,758.74 10 5.29%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 Deutsche Bank 2,336.07 15 8.07%
2 JPMorgan 2,260.62 16 7.81%
3 BNP Paribas 2,167.79 20 7.49%
4 Citi 1,935.99 15 6.69%
5 Goldman Sachs 1,890.62 15 6.53%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 12,355.10 94 10.23%
2 Citi 11,234.36 86 9.30%
3 Goldman Sachs 8,483.82 60 7.02%
4 Bank of America Merrill Lynch 8,431.45 69 6.98%
5 Morgan Stanley 7,524.77 55 6.23%